close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cansino Biologics Inc (OP:CASBF)

3.900 +0.755 (+24.01%)
Streaming Delayed Price Updated: 9:33 AM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cansino Biologics Inc

News headline image
CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline
From CanSino Biologics Inc
Via ACN Newswire
News headline image
CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America
Via ACN Newswire
News headline image
CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion
Via ACN Newswire
News headline image
CanSinoBIO: From Profit Turnaround to Value Realization as an Innovative Vaccine Leader
Via ACN Newswire
News headline image
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
From CanSino Biologics Inc
Via ACN Newswire
News headline image
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Via ACN Newswire
News headline image
CanSino Receives Another Strong Boost
Via ACN Newswire
News headline image
CanSinoBIO Reports Outstanding H1 2024 Performance
Via ACN Newswire
News headline image
CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
Via ACN Newswire
News headline image
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Via ACN Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.